ir tranzyme.com

Investor Relations Ocera Therapeutics, Inc.

Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia elevated ammonia in the blood and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all . Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.
traffic

OVERVIEW

The domain ir.tranzyme.com currently has an average traffic ranking of zero (the smaller the superior). We have examined fourteen pages within the site ir.tranzyme.com and found zero websites interfacing with ir.tranzyme.com. There is two social network platforms possessed by ir.tranzyme.com.
Pages Crawled
14
Social Links
2

IR.TRANZYME.COM TRAFFIC

The domain ir.tranzyme.com has seen a fluctuation amounts of traffic through the year.
Traffic for ir.tranzyme.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.tranzyme.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.tranzyme.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

WHAT DOES IR.TRANZYME.COM LOOK LIKE?

Desktop Screenshot of ir.tranzyme.com Mobile Screenshot of ir.tranzyme.com Tablet Screenshot of ir.tranzyme.com

IR.TRANZYME.COM SERVER

We detected that a lone page on ir.tranzyme.com took zero milliseconds to download. I could not observe a SSL certificate, so therefore we consider this site not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
0.0.0.0

BROWSER IMAGE

HTML TITLE

Investor Relations Ocera Therapeutics, Inc.

DESCRIPTION

Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia elevated ammonia in the blood and associated hepatic encephalopathy, a complication of patients with liver cirrhosis. View all . Aug 3, 2015. Ocera Therapeutics Reports Second Quarter 2015 Financial Results.

PARSED CONTENT

The domain ir.tranzyme.com states the following, "Ocera is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need." We observed that the website also said " Oceras lead program, OCR-002, is an ammonia scavenger designed to treat hyperammonemia elevated ammonia in the blood and associated hepatic encephalopathy, a complication of patients with liver cirrhosis." It also stated " Ocera Therapeutics Reports Second Quarter 2015 Financial Results."

SEEK MORE WEBSITES

Investor Relations - Travelzoo

What type of deals? Annual Reports and Proxies. Delayed at least 20 minutes.

TRAVIAN - the online multiplayer strategy game

The time has come, Travian Kingdoms open Beta international server is now. Open! TRAVIAN - the multiplayer strategy game. TRAVIAN is one of the most popular browser games in the world. As a player in TRAVIAN, you will build your own empire, recruit a mighty army, and fight with your allies for game world hegemony. Register here for free! International open beta server. Become part of our community now! 2004 - 2015 .

Investor Relations Home Tredegar

A GLOBAL MANUFACTURER OF PLASTIC FILMS AND ALUMINUM EXTRUSIONS. Returns and a reputation for consistently delivering on its. Click Here for Investor Presentations. Tredegar Reports Second-Quarter 2015 Results. Tredegar Announces Schedule for Second-Quarter Earnings. Tredegar Downsizing Film Products Facility in Lake Zurich, IL.

Investor Relations - TriMas Corporation

We have laid the foundation for sustainable sales and earnings growth through a disciplined approach to investment and capital allocation. Through selective organic growth strategies such as product innovation, market penetration and geographic expansion, and bolt-on acquisitions, we provide our customers with highly-engineered solutions in a variety of growing and markets. TriMas Aerospace Receives Supplier Award From Airbus.

Investor Relations Overview Trina Solar

Trina Solar Announces Results of 2015 Annual General Meeting of Shareholders and Changes to the Board Committees Composition. Trina Solar Conflict Minerals Policy.